An edition of Case studies in modern drug discovery and development
(2012)
Case studies in modern drug discovery and development
by Xianhai Huang
Share
×Close
This edition doesn't have a description yet. Can you add one?
Check nearby libraries
Buy this book
Showing 6 featured editions. View all 6 editions?
| Edition | Availability |
|---|---|
1
Case Studies in Modern Drug Discovery and Development
2012, Wiley & Sons, Incorporated, John
in English
1118219708 9781118219706
|
zzzz
Libraries near you:
WorldCat
|
|
2
Case Studies in Modern Drug Discovery and Development
2012, Wiley & Sons, Incorporated, John
in English
1280591005 9781280591006
|
zzzz
Libraries near you:
WorldCat
|
|
3
Case Studies in Modern Drug Discovery and Development
2012, Wiley & Sons, Incorporated, John
in English
1118219678 9781118219676
|
zzzz
Libraries near you:
WorldCat
|
|
4
Case studies in modern drug discovery and development
2012, John Wiley & Sons
in English
0470601817 9780470601815
|
aaaa
Libraries near you:
WorldCat
|
|
5
Case Studies in Modern Drug Discovery and Development
2012, Wiley & Sons, Incorporated, John
in English
1118219694 9781118219690
|
zzzz
Libraries near you:
WorldCat
|
|
6
Case Studies in Modern Drug Discovery and Development
2012, Wiley & Sons, Limited, John
in English
1118219686 9781118219683
|
zzzz
Libraries near you:
WorldCat
|
Book Details
Table of Contents
Introduction: drug discovery in difficult times / Malcom MacCoss
Discovery and development of the DPP-4 inhibitor JANUVIA? (Sitagliptin) / Emma R. Parmee ... [et al.]
Olmesartan medoxiomil, an angiotensin II receptor blocker / Hiroaki Yanagisawa, Hiroyuki Koike, and Shinichiro Miura
Discovery of heterocyclic phosphonic acids as novel AMP mimics that are potent and selective fructose-1,6-bisphosphatase inhibitors and elicit potent glucose-lowering effects in diabetic animals and human / Qun Dang, and Mark D. Erion
Setting the paradigm of targeted drugs for the treatment of cancer : Imatinib and Nilotinib therapies for chronic myelogenous leukaemia / Paul W. Manley and Jürg Zimmermann
Amrubicin, a completely synthetic 9-aminoanthracycline, for extensive-disease small-cell lung cancer / Mitsuharu Hanada
The discovery of dual IGF-1R and IR inhibitor FQIT for the treatment of cancer / Meizhong Jin, Elizabeth Buck, and Mark J. Mulvihill
Discovery and development of Montelukast (Singulair?) / Robert N. Young
Discovery and development of Maraviroc, a CCR5 antagonist for the treatment of HIV Infection / Patrick Dorr, Blanda Stammen, Elna van der Ryst
Discovery of antimalarial drug Artemisinin and beyond / Ao Zhang, Weiwei Mao, Yu Zhang
Discovery and process development of MK-4965, a potent non-nucleoside reverse transcriptase inhibitor / Yong-Li Zhong, Thomas J. Tucker, and Jingjun Yin
Discovery of Boceprevir and Narlaprevir : the first and second generation of HCV NS3 protease inhibitors / Kevin X. Chen, F. George Njoroge
The discovery of Samsca (Tolvaptan) : the first oral nonpeptide vasopressin receptor antagonist / Kazumi Kondo, Yoshitaka Yamamura
SILODOSIN (Urief?, Rapaflo?, Thrupas?, Urorec?, SilodixTM) : a selective à1A adrenoceptor antagonist for the treatment of benign prostatic hyperplasia / Masaki Yoshida ... [et al.]
Raloxifene : a selective estrogen receptor modulator (SERM) / Jeffrey A. Dodge and Henry U. Bryant.
Edition Notes
Includes bibliographical references and index.
Classifications
The Physical Object
ID Numbers
Community Reviews (0)
Feedback?
History
- Created October 23, 2011
- 5 revisions
Wikipedia citation
×CloseCopy and paste this code into your Wikipedia page. Need help?
| August 25, 2024 | Edited by MARC Bot | import existing book |
| October 9, 2020 | Edited by ImportBot | import existing book |
| September 25, 2020 | Edited by MARC Bot | import existing book |
| August 2, 2020 | Edited by ImportBot | import existing book |
| October 23, 2011 | Created by LC Bot | Imported from Library of Congress MARC record |